1 / 12

Contraceptives Market - Global Industry Analysis, Trends and Forecast 2014 – 2020

Contraceptives are defined as drugs and devices that help in preventing pregnancy. These devices also prevent spreading of sexually transmitted infection. Various awareness initiatives taken by market players is the major factor propelling the growth of contraceptives market. Bayer HealthCare, a major player in the contraceptives market, in coalition with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take right decision about their reproductive health.<br>

amyjames
Télécharger la présentation

Contraceptives Market - Global Industry Analysis, Trends and Forecast 2014 – 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 Published Date 17-12-2014 106 Page Report Request Sample Buy Now Press Release Global Contraceptives Market to Grow to US$19.6 Billion, APAC to Dominate Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Contraceptives Market REPORT DESCRIPTION A new report published by Transparency Market Research (TMR) has published a report titled “Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. The report studies the strengths, weaknesses, opportunities, and threats that abound in this market. According to the report, the global contraceptives market was valued at US$15.7 billion in 2013 and is expected to reach a value of US$19.6 billion in 2020, growing at a CAGR of 3.1% from 2014 to 2020. It also offers expert advice on the growth of this market, the factors likely to support the same, and the ones that will inhibit its growth. Browse the full Contraceptives Market (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, Sub-Dermal Contraceptive Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at: http://www.transparencymarketresearch.com/contraceptives-market.html Contraceptives are drugs and devices that enable prevention of an unwanted pregnancy. The other important function of the devices is to prevent transfer of sexually transmitted diseases or infections. Initiatives taken by the government and organizations to control population and promote safer sex are the main growth drivers for the global contraceptives market. The global contraceptives market is segmented by products and geography. The products segment is further broken down into drugs, such as topical contraceptives, injectables, and oral contraceptive pills. The next sub-segment is devices, which consists of male contraceptive devices (such as condoms) and female contraceptive devices such as female condoms, sub- dermal contraceptive implants, contraceptive vaginal rings, intrauterine devices, contraceptive diaphragm, contraceptive sponges, and non-surgical permanent contraception device. Geographically, the global contraceptives market is fragmented into North America, Europe, Asia Pacific, and Rest of the World. Request a Brochure of this : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344 2 Transparency Market Research

  3. Contraceptives Market Out of all these segments, contraceptive devices held the biggest market share, at about 60%, in 2013. This segment owes its huge success to the popularity of devices such as copper IUDs, male condoms, and inexpensive sub-dermal contraceptive implants such as sino-implants. By 2020, the contraceptive devices segment is expected to grow at a CAGR of more than 3.5%. The contraceptives market is expected to witness a steady growth rate; the introduction of female condoms such as Bayer’s Skyla in the U.S. market and Jaydess in the European market will encourage this segment to expand in newer directions. Additionally, reduction in the price of Jadelle, a subdermal implant by Bayer HealthCare will also support the contraceptives market in the coming few years. Browse the full Press Release: http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htm In terms of geography, North America held a dominant market share of more than 40% in 2013. However, Asia Pacific is expected to dominate this region with a CAGR of 4.5% in the forecast period. Countries such as India and China will contribute significantly to this phenomenon with their huge population base, rising disposable incomes, and growing awareness about the usage of contraceptives. Some of the major market players profiled in this report are Bayer AG, Actavis Inc., CooperSurgical Inc., Church & Dwight Co. Inc., Mayer Laboratories Inc., Merck & Co. Inc., Reckitt Benckiser plc, Pfizer Inc., The Female Health Company, and Teva Pharmaceutical Industries Ltd. TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 3 Transparency Market Research

  4. Contraceptives Market 1.3 Research Methodology 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Snapshot: Global Contraceptives Market 2.2 Comparative Analysis: Global Contraceptives Market, by Geography, 2013 & 2020 (Value %) Chapter 3 Global Contraceptives Market Overview 3.1 Introduction 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.1.1 High incident rate of unintended pregnancies is leading to unmet contraceptive needs, hence driving the contraceptives market 3.2.1.2 Awareness programs by government and NGOs are promoting the use of contraceptives globally 3.2.1.3 Implementation of the Patient Protection Act or the Affordable Care Act increased the use of contraceptives in North America 3.2.2 Market Restraints 3.2.2.1 Side effects associated with the use of contraceptive drugs and devices induce people to opt for natural and permanent contraceptive methods 3.2.2.2 Rising prevalence of infertility among women and aging population are limiting the use of contraceptives 3.2.2.3 Ethical and social issues restrict the use or subsidies on contraceptives in some countries 4 Transparency Market Research

  5. Contraceptives Market 3.2.3 Market Opportunities 3.2.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies would drive the contraceptives market 3.2.3.2 Presence of strong contraceptive pipeline would support the global contraceptives market during the forecast period 3.3 Porter’s Five Forces Analysis: Global Contraceptives Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of Substitutes 3.3.4 Threat of New Entrants 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis: Global Contraceptives Market, by Geography 3.5 Competitive Landscape: Global Contraceptives Market, by Key Players 3.5.1 Heat Map Analysis for Key Market Players: Global Contraceptive Drugs Market 3.5.2 Heat Map Analysis for Key Market Players: Global Contraceptive Devices Market Chapter 4 Global Contraceptives Market, by Product Type 4.1 Introduction 4.1.1 Comparative Analysis: Global Contraceptives Market Revenue, by Product Type, 2013 & 2020 (%) 4.2 Contraceptive Drugs 4.2.1 Global Contraceptive Drugs Market Revenue, by Drug Type, 2012 – 2020 (USD Million) 5 Transparency Market Research

  6. Contraceptives Market 4.2.2 Oral Contraceptive Pills 4.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2012 – 2020 (USD Million) 4.2.3 Contraceptive Injectables 4.2.3.1 Global Contraceptive Injectables Market Revenue, 2012 – 2020 (USD Million) 4.2.4 Topical Contraceptives 4.2.4.1 Global Topical Contraceptives Market Revenue, 2012 – 2020 (USD Million) 4.3 Contraceptive Devices 4.3.1 Comparative Analysis: Global Contraceptive Devices Market, by Device Type, 2013 & 2020 (%) 4.3.2 Male Contraceptive Devices (Male Condoms) 4.3.2.1 Global Male Contraceptive Devices Market Revenue, 2012 – 2020 (USD Million) 4.3.2.2 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Segment 4.3.3 Female Contraceptive Devices 4.3.3.1 Global Female Contraceptive Devices Market Revenue, by Device Type, 2012 – 2020 (USD Million) 4.3.3.2 Female Condoms 4.3.3.2.1 Global Female Condoms Market Revenue, 2012 – 2020 (USD Million) 4.3.3.3 Contraceptive Diaphragms 4.3.3.3.1 Global Contraceptive Diaphragms Market Revenue, 2012 – 2020 (USD Million) 4.3.3.4 Contraceptive Sponges 4.3.3.4.1 Global Contraceptive Sponges Market Revenue, 2012 – 2020 (USD Million) 4.3.3.5 Contraceptive Vaginal Rings 6 Transparency Market Research

  7. Contraceptives Market 4.3.3.5.1 Global Contraceptive Vaginal Rings Market Revenue, 2012 – 2020 (USD Million) 4.3.3.6 Intrauterine Devices 4.3.3.6.1 Global Intrauterine Devices Market Revenue, 2012 – 2020 (USD Million) 4.3.3.7 Subdermal Contraceptive Implants 4.3.3.7.1 Global Subdermal Implants Market Revenue, 2012 – 2020 (USD Million) 4.3.3.8 Non-Surgical Permanent Contraception Devices 4.3.3.8.1 Global Non-Surgical Permanent Contraception Devices Market Revenue, 2012 – 2020 (USD Million) Chapter 5 Global Contraceptives Market, by Geography 5.1 Overview 5.1.1 Global Contraceptives Market Revenue, by Geography, 2012 – 2020 (USD Million) 5.2 North America 5.2.1 North America Contraceptives Market Revenue, 2012 – 2020 (USD Million) 5.2.2 North America Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million) 5.3 Europe 5.3.1 Europe Contraceptives Market Revenue, 2012 – 2020 (USD Million) 5.3.2 Europe Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million) 5.4 Asia Pacific 5.4.1 Asia Pacific Contraceptives Market Revenue, 2012 – 2020 (USD Million) 5.4.2 Asia Pacific Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million) 7 Transparency Market Research

  8. Contraceptives Market 5.5 Rest of the World (RoW) 5.5.1 Rest of the World Contraceptives Market Revenue, 2012 – 2020 (USD Million) 5.5.2 Rest of the World Contraceptives Market, by Products (Drugs & Devices), 2012 – 2020 (USD Million) Chapter 6 Recommendations 6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies 6.2 Making Rigorous R&D Initiatives 6.3 Investing in Marketing Campaigns to Elevate Customer Awareness 6.4 Tracking Patent Expiration of Branded Products Chapter 7 Company Profiles 7.1 Actavis, Inc. 7.1.1 Company Overview 7.1.2 Financial Overview 7.1.3 Product Portfolio 7.1.4 Business Strategies 7.1.5 Recent Developments 7.2 Bayer AG 7.2.1 Company Overview 7.2.2 Financial Overview 8 Transparency Market Research

  9. Contraceptives Market 7.2.3 Product Portfolio 7.2.4 Business Strategies 7.2.5 Recent Developments 7.3 Church & Dwight Co., Inc. 7.3.1 Company Overview 7.3.2 Financial Overview 7.3.3 Product Portfolio 7.3.4 Business Strategies 7.3.5 Recent Developments 7.4 CooperSurgical, Inc. 7.4.1 Company Overview 7.4.2 Financial Overview 7.4.3 Product Portfolio 7.4.4 Business Strategies 7.4.5 Recent Developments 7.5 Mayer Laboratories, Inc. 7.5.1 Company Overview 7.5.2 Financial Overview 7.5.3 Product Portfolio 7.5.4 Business Strategies 7.5.5 Recent Developments 9 Transparency Market Research

  10. Contraceptives Market 7.6 Merck & Co., Inc. 7.6.1 Company Overview 7.6.2 Financial Overview 7.6.3 Product Portfolio 7.6.4 Business Strategies 7.6.5 Recent Developments 7.7 Pfizer, Inc. 7.7.1 Company Overview 7.7.2 Financial Overview 7.7.3 Product Portfolio 7.7.4 Business Strategies 7.7.5 Recent Developments 7.8 Reckitt Benckiser plc 7.8.1 Company Overview 7.8.2 Financial Overview 7.8.3 Product Portfolio 7.8.4 Business Strategies 7.8.5 Recent Developments 7.9 Teva Pharmaceutical Industries Ltd. 7.9.1 Company Overview 7.9.2 Financial Overview 10 Transparency Market Research

  11. Contraceptives Market 7.9.3 Product Portfolio 7.9.4 Business Strategies 7.9.5 Recent Developments 7.10 The Female Health Company 7.10.1 Company Overview 7.10.2 Financial Overview 7.10.3 Product Portfolio 7.10.4 Business Strategies 7.10.5 Recent Developments About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward- looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact Transparency Market Research 11 Transparency Market Research

  12. Contraceptives Market 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ 12 Transparency Market Research

More Related